Chemotherapy
Information
- Drug Name
- Chemotherapy
- Description
- Entry(CIViC)
- 12
CIViC
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Meta-Analysis of 12 studies with 2,266 patients (5... | KRAS | KRAS MUTATION KRAS MUTATION | Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Chemotherapy-refractory patients with metastatic c... | KRAS | KRAS G12/G13 KRAS G12/G13 | Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Cancer and normal tissue samples were taken from 6... | PTEN |
PTEN DELETION ( ENST00000371953.8 ) PTEN DELETION ( ENST00000371953.8 ) |
Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Study evaluated a total of 50 small cell lung canc... | RB1 | RB1 LOSS-OF-FUNCTION RB1 LOSS-OF-FUNCTION | Sensitivity | true | CIViC Evidence | detail |
| This was a retrospective study of 605 patients wit... | KRAS | KRAS MUTATION KRAS MUTATION | Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Six patients participating in a large retrospectiv... | KRAS |
KRAS p.Gln61His (p.Q61H) ( ENST00000256078.10, ENST00000311936.8, ENST00000557334.6, ENST00000685328.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 ) KRAS p.Gln61His (p.Q61H) ( ENST00000256078.10, ENST00000311936.8, ENST00000557334.6, ENST00000685328.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 ) |
Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Two patients participating in a large retrospectiv... | KRAS |
KRAS p.Gln61Leu (p.Q61L) ( ENST00000256078.10, ENST00000311936.8, ENST00000557334.6, ENST00000685328.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 ) KRAS p.Gln61Leu (p.Q61L) ( ENST00000256078.10, ENST00000311936.8, ENST00000557334.6, ENST00000685328.1, ENST00000688940.1, ENST00000692768.1, ENST00000693229.1 ) |
Resitance or Non-Reponse | true | CIViC Evidence | detail |
| Two patients participating in a large retrospectiv... | KRAS |
KRAS p.Gln61Lys (p.Q61K) ( ENST00000311936.8, ENST00000693229.1, ENST00000692768.1, ENST00000557334.6, ENST00000688940.1, ENST00000256078.10, ENST00000685328.1 ) KRAS p.Gln61Lys (p.Q61K) ( ENST00000693229.1, ENST00000688940.1, ENST00000692768.1, ENST00000256078.10, ENST00000311936.8, ENST00000557334.6, ENST00000685328.1 ) |
Resitance or Non-Reponse | true | CIViC Evidence | detail |
| This was a retrospective study of 605 patients wit... | KRAS | KRAS Q61 KRAS Q61 | Resitance or Non-Reponse | true | CIViC Evidence | detail |
| This was a retrospective study of 605 patients wit... | KRAS | KRAS A146 KRAS A146 | Resitance or Non-Reponse | false | CIViC Evidence | detail |
| In this meta-analysis of 13 studies (564 patients)... | TP53 | TP53 DELETERIOUS MUTATION TP53 DELETERIOUS MUTATION | Sensitivity | true | CIViC Evidence | detail |
| Patients with p53 wild type (as defined by low exp... | TP53 | TP53 WILD TYPE TP53 WILD TYPE | Sensitivity | true | CIViC Evidence | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03599752 | Active, not recruiting | Phase 2 | Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases | July 2, 2018 | January 31, 2030 |
| NCT02738606 | Active, not recruiting | Phase 2 | Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery | May 25, 2016 | December 31, 2025 |
| NCT02679040 | Active, not recruiting | Phase 2 | Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy | January 27, 2016 | February 2025 |
| NCT02392429 | Active, not recruiting | Phase 2 | FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia | April 20, 2016 | February 13, 2025 |
| NCT03943173 | Active, not recruiting | Early Phase 1 | Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery | June 7, 2019 | March 22, 2024 |
| NCT02671890 | Active, not recruiting | Phase 1 | Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer | February 25, 2016 | May 5, 2025 |
| NCT04082364 | Active, not recruiting | Phase 2/Phase 3 | Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer | September 30, 2019 | June 2025 |
| NCT03599960 | Active, not recruiting | Phase 2 | Combination Chemotherapy in Patients With Newly Diagnosed BPDCN | May 2, 2019 | November 2024 |
| NCT05569811 | Active, not recruiting | Phase 2 | NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial | November 25, 2022 | July 31, 2030 |
| NCT04201561 | Active, not recruiting | Phase 3 | High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy | December 24, 2019 | December 31, 2024 |
| NCT03691441 | Active, not recruiting | Phase 4 | Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer | January 5, 2018 | May 5, 2024 |
| NCT03443856 | Active, not recruiting | Phase 2 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence | July 17, 2019 | June 2026 |
| NCT05513573 | Active, not recruiting | Phase 2 | Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC | December 14, 2022 | September 30, 2026 |
| NCT05488626 | Active, not recruiting | N/A | Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer | October 20, 2022 | December 2025 |
| NCT02151981 | Active, not recruiting | Phase 3 | AZD9291 (Osimertinib) Versus Platinum-Based Doublet-Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer | August 4, 2014 | December 29, 2023 |
| NCT04230759 | Active, not recruiting | Phase 2 | Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group | January 7, 2020 | March 31, 2027 |
| NCT04364048 | Active, not recruiting | Phase 2 | Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer | June 18, 2020 | December 31, 2024 |
| NCT06102057 | Active, not recruiting | Phase 2 | PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC | February 27, 2024 | June 2028 |
| NCT03409614 | Active, not recruiting | Phase 3 | Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer | March 6, 2018 | February 3, 2025 |
| NCT03070366 | Active, not recruiting | Phase 2 | Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC | September 21, 2015 | July 2026 |
| NCT03544736 | Active, not recruiting | Phase 1/Phase 2 | Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) | April 26, 2018 | December 31, 2040 |
| NCT03353831 | Active, not recruiting | Phase 3 | Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer | September 11, 2018 | December 1, 2024 |
| NCT03721341 | Active, not recruiting | Phase 3 | Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors | February 22, 2019 | January 2029 |
| NCT06445816 | Active, not recruiting | Does the Level of Pain in Pediatric Oncology Patients Affect the Level of Psychological Resilience in Parents? | May 1, 2023 | July 1, 2024 | |
| NCT01154920 | Active, not recruiting | Phase 2 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | July 9, 2010 | December 31, 2025 |
| NCT01013649 | Active, not recruiting | Phase 3 | Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | April 5, 2010 | February 13, 2025 |
| NCT03018418 | Active, not recruiting | Phase 2 | Proton Therapy in Reducing Toxicity in Anal Cancer | January 4, 2017 | July 2024 |
| NCT06019520 | Active, not recruiting | N/A | Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity | August 9, 2023 | March 9, 2024 |
| NCT00938145 | Active, not recruiting | N/A | 3 Tesla MRI in Patients With Bladder Cancer | July 8, 2009 | December 31, 2024 |
| NCT03283384 | Active, not recruiting | Phase 2 | Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. | June 15, 2019 | August 2027 |
| NCT04581824 | Active, not recruiting | Phase 2 | Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) | November 19, 2020 | October 20, 2025 |
| NCT03873883 | Active, not recruiting | Phase 1 | First-in-Human Study of EOS100850 in Patients With Cancer | January 28, 2019 | July 2024 |
| NCT04905316 | Active, not recruiting | Phase 2 | A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer | May 21, 2021 | May 2025 |
| NCT03939481 | Active, not recruiting | Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer | May 14, 2019 | February 28, 2026 | |
| NCT00019461 | Completed | Phase 2 | Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | April 1998 | October 2007 |
| NCT00021034 | Completed | Phase 1 | Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | March 2001 | August 2001 |
| NCT00030771 | Completed | Phase 3 | Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients | April 4, 2001 | September 15, 2023 |
| NCT00033397 | Completed | Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery | February 2002 | May 1, 2012 | |
| NCT00041808 | Completed | Phase 1/Phase 2 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | July 2001 | April 2003 |
| NCT00048633 | Completed | Phase 2 | Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer | November 2001 | June 2003 |
| NCT00068068 | Completed | Phase 2 | Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases | October 2003 | |
| NCT00070616 | Completed | Phase 1 | Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support | December 2001 | March 2005 |
| NCT00070629 | Completed | Phase 2 | CPG 7909 Injection in Non-Small Cell Lung Cancer | May 2003 | July 2007 |
| NCT00070642 | Completed | Phase 2 | CPG 7909 Injection in Melanoma | December 2003 | December 2005 |
| NCT03248570 | Completed | Phase 2 | Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects | February 20, 2018 | September 28, 2023 |
| NCT00083785 | Completed | Phase 2 | Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases | May 2004 | |
| NCT00087776 | Completed | N/A | Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma | October 2002 | |
| NCT00108290 | Completed | Phase 2 | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | April 2004 | March 2007 |
| NCT05840068 | Completed | Phase 4 | IGF Level in Breast Cancer Patients Treated With Metformin | June 1, 2020 | July 31, 2021 |
| NCT00117572 | Completed | Phase 3 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | November 2004 | December 2016 |
| NCT05718466 | Completed | Phase 3 | Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy | November 2010 | December 2016 |
| NCT00002496 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | August 1992 | November 2013 |
| NCT00246571 | Completed | Phase 2 | Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer | January 2006 | June 2011 |
| NCT00256789 | Completed | N/A | Once Weekly Radiation for Lung Cancer With Chemotherapy | September 2002 | December 2004 |
| NCT00256815 | Completed | Phase 1/Phase 2 | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study | March 2003 | September 2005 |
| NCT00274755 | Completed | Phase 2 | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas | November 2003 | |
| NCT05410938 | Completed | Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy | June 6, 2022 | May 1, 2023 | |
| NCT00335829 | Completed | Phase 2 | Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery | May 2006 | February 2011 |
| NCT00373191 | Completed | Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery | May 2006 | December 2013 | |
| NCT00382018 | Completed | Phase 3 | S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo | October 2006 | July 11, 2017 |
| NCT00388895 | Completed | Phase 2 | Glivec in Ph Positive Lymphoblastic Leukemia | June 2002 | October 2007 |
| NCT05364905 | Completed | Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma | May 9, 2022 | November 22, 2022 | |
| NCT00390715 | Completed | Treatment of Acute Myeloblastic Leukemia in Younger Patients | January 1999 | January 2010 | |
| NCT00403403 | Completed | Phase 2 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | March 2007 | June 2009 |
| NCT00416897 | Completed | Phase 3 | Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure | March 2003 | December 2008 |
| NCT00448279 | Completed | Phase 3 | THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | April 2007 | September 2010 |
| NCT00455936 | Completed | Phase 3 | First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker | October 2005 | March 2010 |
| NCT00460421 | Completed | Phase 1 | A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT | August 2006 | May 2011 |
| NCT00074152 | Completed | Phase 3 | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer | July 2002 | August 22, 2016 |
| NCT00002711 | Completed | Phase 1 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | October 1995 | October 2000 |
| NCT03236857 | Completed | Phase 1 | A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies | November 8, 2017 | April 19, 2023 |
| NCT03181126 | Completed | Phase 1 | A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma | November 27, 2017 | November 14, 2020 |
| NCT03067610 | Completed | Phase 2 | Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer | January 20, 2017 | March 9, 2021 |
| NCT03101514 | Completed | Phase 2 | Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study | January 1, 2017 | February 1, 2021 |
| NCT00002725 | Completed | Phase 2 | Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | August 1996 | |
| NCT03151642 | Completed | A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION | April 5, 2017 | April 23, 2021 | |
| NCT00002734 | Completed | Phase 1 | Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer | March 1996 | |
| NCT00002737 | Completed | Phase 3 | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | March 1996 | |
| NCT00002824 | Completed | Phase 1 | Gene Therapy in Treating Patients With Primary Brain Tumors | February 1996 | |
| NCT06461598 | Completed | Signature for Precise Chemosensitivity Prediction in PDAC | January 1, 2018 | May 31, 2021 | |
| NCT00002895 | Completed | Phase 3 | Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer | June 1996 | October 2010 |
| NCT00002909 | Completed | Phase 1 | Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma | February 1997 | |
| NCT00003131 | Completed | Phase 2 | CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse | February 1997 | February 2002 |
| NCT00003196 | Completed | N/A | Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma | September 1997 | April 2002 |
| NCT00003249 | Completed | Phase 1 | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | May 1998 | |
| NCT00003358 | Completed | Phase 1 | Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | January 1998 | |
| NCT00003387 | Completed | Phase 3 | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | July 1998 | April 2009 |
| NCT00003673 | Completed | Phase 2 | CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse | March 1998 | March 1999 |
| NCT00003695 | Completed | Phase 3 | Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer | May 1998 | January 2001 |
| NCT00003974 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma | August 1997 | November 2000 |
| NCT00003996 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | May 1999 | May 2008 |
| NCT00004038 | Completed | Phase 1 | Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer | January 1999 | |
| NCT00004202 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer | October 1998 | January 2003 |
| NCT00004867 | Completed | N/A | Positron Emission Tomography in Determining Stage of Esophageal Cancer | November 1999 | January 2009 |
| NCT00004891 | Completed | N/A | PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery | September 1999 | |
| NCT00005046 | Completed | Phase 1 | Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | April 2000 | |
| NCT00005848 | Completed | Phase 2 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | April 2000 | May 2007 |
| NCT00006241 | Completed | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma | March 2000 | October 2000 |
| NCT00006376 | Completed | Phase 2 | R115777 in Treating Patients With Advanced Bladder Cancer | March 2000 | May 2005 |
| NCT00006480 | Completed | Phase 1 | Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | May 2000 | March 2005 |
| NCT00019058 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Glioblastoma | April 1995 | |
| NCT00019071 | Completed | Phase 1 | Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma | March 1995 | |
| NCT03646591 | Completed | Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China | November 15, 2017 | August 20, 2018 | |
| NCT02247037 | Completed | Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast Cancer | July 2014 | January 22, 2019 | |
| NCT03632135 | Completed | Phase 3 | Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma | May 20, 2018 | December 31, 2023 |
| NCT00002631 | Completed | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | June 1995 | |
| NCT00002639 | Completed | Phase 2 | Suramin in Treating Patients With Recurrent Primary Brain Tumors | July 1995 | May 2004 |
| NCT02305615 | Completed | An Observational Study of Continued Bevacizumab Plus Chemotherapy Until First Progression in Participants With Metastatic Colorectal Cancer (CRC) | January 13, 2015 | December 29, 2017 | |
| NCT02327078 | Completed | Phase 1/Phase 2 | A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) | November 26, 2014 | June 16, 2020 |
| NCT02405078 | Completed | Early Phase 1 | Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | October 13, 2015 | October 3, 2022 |
| NCT02448420 | Completed | Phase 2 | Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer | July 2015 | November 30, 2023 |
| NCT02461290 | Completed | Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1 | April 2008 | November 2013 | |
| NCT02467426 | Completed | Isolated Thoracic Perfusion (ITP-F) for MPM | September 2009 | May 2015 | |
| NCT02472756 | Completed | A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma | September 19, 2008 | May 30, 2014 | |
| NCT03547804 | Completed | Phase 2 | A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer | May 31, 2018 | September 1, 2020 |
| NCT02528175 | Completed | N/A | Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer | April 2015 | April 2022 |
| NCT02620423 | Completed | Phase 1 | Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma | December 2015 | August 2018 |
| NCT00002654 | Completed | Phase 3 | Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer | April 1994 | July 2000 |
| NCT02644408 | Completed | Phase 3 | Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy | October 1, 2014 | December 1, 2020 |
| NCT03524391 | Completed | N/A | Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients | February 12, 2016 | February 25, 2017 |
| NCT02668653 | Completed | Phase 3 | Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) | September 1, 2016 | June 16, 2023 |
| NCT02728622 | Completed | Phase 3 | Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane | March 2002 | January 2009 |
| NCT03512197 | Completed | Phase 3 | A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) | July 20, 2018 | February 12, 2021 |
| NCT03491033 | Completed | Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy | August 28, 2017 | October 31, 2017 | |
| NCT02782845 | Completed | Phase 4 | An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) | June 2006 | October 2007 |
| NCT02797197 | Completed | N/A | Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy | May 18, 2016 | February 15, 2017 |
| NCT00002670 | Completed | Phase 3 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery | September 1995 | November 2013 |
| NCT02818725 | Completed | Phase 3 | I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations | June 2010 | September 2017 |
| NCT03410693 | Completed | Phase 2/Phase 3 | Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma | May 31, 2018 | October 27, 2020 |
| NCT02831842 | Completed | A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status | June 9, 2016 | November 30, 2017 | |
| NCT00002677 | Completed | Phase 1 | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors | August 1995 | March 2003 |
| NCT02855944 | Completed | Phase 3 | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients | March 1, 2017 | September 16, 2022 |
| NCT03390608 | Completed | Prognostic and Predictive Factors for Small Breast Tumors | January 1, 1977 | July 30, 2016 | |
| NCT03353675 | Completed | Phase 2 | A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) | January 5, 2018 | February 17, 2021 |
| NCT03351361 | Completed | Phase 3 | Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients | February 19, 2018 | July 31, 2022 |
| NCT03348241 | Completed | Phase 2 | Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study | October 26, 2015 | August 2016 |
| NCT03339804 | Completed | N/A | Neurovascular Changes Induced by Chemotherapy | February 22, 2016 | October 1, 2017 |
| NCT03329950 | Completed | Phase 1 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | December 1, 2017 | September 13, 2022 |
| NCT02969681 | Completed | Phase 3 | Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer | January 2017 | December 30, 2020 |
| NCT02984501 | Completed | Phase 2 | Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer | March 2013 | August 2016 |
| NCT00589121 | Completed | Phase 2 | Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg | March 2008 | May 21, 2018 |
| NCT00639366 | Completed | Phase 3 | Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer | February 2007 | October 2010 |
| NCT00640796 | Completed | Phase 1 | Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors | September 2008 | April 2014 |
| NCT00659269 | Completed | Phase 3 | A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients | July 2006 | June 2015 |
| NCT00664911 | Completed | Phase 4 | Combination Chemotherapy in Treating Older Patients With Solid Tumour, | March 2008 | October 2013 |
| NCT00696735 | Completed | Phase 3 | High-Dose Therapy Treatment in Patients With Follicular Lymphoma | June 1994 | May 2006 |
| NCT00700102 | Completed | Phase 3 | A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. | February 2006 | May 2013 |
| NCT00711191 | Completed | Phase 1 | A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas | June 2008 | January 2011 |
| NCT00732563 | Completed | N/A | Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery | July 16, 2008 | July 26, 2017 |
| NCT00739830 | Completed | Phase 2 | Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) | August 2008 | July 2012 |
| NCT00768755 | Completed | Phase 1/Phase 2 | Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer | January 2009 | March 2012 |
| NCT00821990 | Completed | Phase 3 | Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer | September 2008 | June 2011 |
| NCT04882371 | Completed | Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer | January 1, 2018 | August 1, 2020 | |
| NCT00842712 | Completed | Phase 2 | Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) | February 2009 | July 2013 |
| NCT00864266 | Completed | N/A | Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer | March 2009 | June 2020 |
| NCT00864331 | Completed | Phase 3 | Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy | February 2008 | November 2012 |
| NCT00870168 | Completed | N/A | Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer | January 2006 | |
| NCT00993694 | Completed | Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone | January 2009 | December 2009 | |
| NCT01015261 | Completed | Phase 2/Phase 3 | Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients | October 2008 | September 2010 |
| NCT01102231 | Completed | Phase 2 | Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) | March 2010 | December 2015 |
| NCT01126190 | Completed | Phase 3 | Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel | June 30, 2010 | February 29, 2012 |
| NCT01163305 | Completed | PET-CT and Circulating Tumor Cells in Colorectal Cancer | June 30, 2010 | April 27, 2017 | |
| NCT01180335 | Completed | Phase 3 | Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer | January 2009 | December 2011 |
| NCT01209507 | Completed | Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy | February 2010 | November 2015 | |
| NCT01211275 | Completed | Phase 1/Phase 2 | Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma | May 22, 2009 | May 6, 2013 |
| NCT01224093 | Completed | An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) | October 2010 | February 2014 | |
| NCT01243047 | Completed | Phase 2 | Intermittent Versus Continuous Tarceva Study | September 2007 | October 2012 |
| NCT01245062 | Completed | Phase 3 | GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma | November 22, 2010 | December 16, 2016 |
| NCT01250379 | Completed | Phase 3 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | February 2011 | March 2015 |
| NCT01290926 | Completed | Phase 2 | Sorafenib Plus Capecitabine Efficacy Assessment in Patients With Advanced Pre-treated Colorectal Cancer | February 2011 | January 2016 |
| NCT01296113 | Completed | Phase 2 | Chemotherapy for Lung Cancer in HIV-positive Patients | May 2011 | July 2017 |
| NCT01298362 | Completed | Impact of Chemotherapy Followed by Aromatase Inhibitors on Bone Health of Women With ER-positive Early Breast Cancer | March 2011 | March 2014 | |
| NCT01342965 | Completed | Phase 3 | A Study of Erlotinib (Tarceva) Versus Gemcitabine/Cisplatin as First-line Treatment in Patients With Non-small Cell Lung Cancer With EGFR Mutations | March 2011 | April 2014 |
| NCT01362127 | Completed | Phase 2 | Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardia | October 2006 | June 25, 2018 |
| NCT01365208 | Completed | New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer | July 2011 | March 3, 2017 | |
| NCT01425736 | Completed | Phase 2 | Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma | January 2009 | March 2013 |
| NCT01470417 | Completed | Phase 2 | Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma | October 2011 | October 2019 |
| NCT01475331 | Completed | Phase 2 | The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts | November 2011 | January 2017 |
| NCT01478854 | Completed | N/A | Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide | December 27, 2011 | April 25, 2018 |
| NCT01504126 | Completed | Early Phase 1 | Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | March 9, 2012 | August 15, 2019 |
| NCT01525953 | Completed | Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis | January 2012 | January 2012 | |
| NCT04146441 | Completed | Phase 2 | Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal Adenocarcinoma | February 10, 2020 | December 31, 2022 |
| NCT01576692 | Completed | Phase 1 | Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma | April 2012 | October 17, 2018 |
| NCT01616238 | Completed | Phase 2 | A Study for Older Adults With Acute Lymphoblastic Leukaemia | December 2012 | February 1, 2023 |
| NCT01648517 | Completed | Phase 2 | Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy | July 27, 2012 | June 30, 2015 |
| NCT04143282 | Completed | Phase 2 | Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment | October 20, 2019 | June 30, 2020 |
| NCT01696669 | Completed | Phase 2 | Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults | March 30, 2010 | January 18, 2018 |
| NCT01696695 | Completed | An Observational Study of First-Line Capecitabine Based Chemotherapy in Participants With Metastatic Colorectal Cancer | July 2011 | December 2014 | |
| NCT01712009 | Completed | Phase 2 | NOLAN: Naproxen or Loratadine and Neulasta | November 1, 2012 | March 18, 2015 |
| NCT01712347 | Completed | An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer | October 11, 2012 | July 1, 2016 | |
| NCT01719536 | Completed | Phase 3 | Icotinib Versus First-line Chemotherapy Plus Maintenance Treatment in EGFR Positive Lung Adenocarcinoma Patients | December 2012 | February 7, 2017 |
| NCT01728155 | Completed | Phase 3 | European Low and Intermediate Risk Neuroblastoma Protocol | January 1, 2011 | |
| NCT01780181 | Completed | Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer | December 2012 | September 2016 | |
| NCT04021589 | Completed | Phase 2 | Chemotherapy w/wo WeiLeShu in Metastatic Colorectal Cancer | July 11, 2019 | October 30, 2021 |
| NCT01807091 | Completed | N/A | Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | May 21, 2013 | January 8, 2020 |
| NCT01829178 | Completed | Phase 2/Phase 3 | Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma | August 2013 | September 2014 |
| NCT03977272 | Completed | Phase 2 | Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer | March 27, 2019 | July 1, 2022 |
| NCT01872819 | Completed | N/A | Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay | August 2, 2013 | November 17, 2014 |
| NCT03874897 | Completed | Phase 1 | Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors. | March 26, 2019 | January 26, 2024 |
| NCT00002519 | Completed | Phase 1 | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer | January 1997 | January 2000 |
| NCT01975454 | Completed | Phase 1/Phase 2 | Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer | April 2012 | December 2017 |
| NCT03838406 | Completed | N/A | BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer | August 1, 2017 | December 31, 2019 |
| NCT02000531 | Completed | Phase 4 | Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population | January 2014 | December 2014 |
| NCT02004262 | Completed | Phase 2 | Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting | February 5, 2014 | August 23, 2016 |
| NCT02042690 | Completed | Phase 3 | Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients | July 2014 | April 2019 |
| NCT02052960 | Completed | Phase 2 | CetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer | February 2014 | October 4, 2017 |
| NCT02064491 | Completed | Phase 2 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | February 2014 | May 31, 2017 |
| NCT02115984 | Completed | Phase 2 | Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer | May 2010 | May 2012 |
| NCT03757858 | Completed | Phase 1/Phase 2 | Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases | March 1, 2018 | June 1, 2023 |
| NCT00002620 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Brain Cancer | November 1994 | |
| NCT02155374 | Completed | Phase 4 | Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy | May 2014 | January 2016 |
| NCT04536467 | Enrolling by invitation | Phase 2 | Prevention of Chemotherapy-Induced Ovarian Failure With Goserelin in Premenopausal Lymphoma Patients | March 1, 2019 | November 1, 2024 |
| NCT05338866 | Enrolling by invitation | Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator | January 1, 2022 | December 31, 2033 | |
| NCT04917289 | Not yet recruiting | Phase 3 | CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients | June 1, 2021 | December 1, 2025 |
| NCT06306560 | Not yet recruiting | Phase 2 | A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC. | March 15, 2024 | April 15, 2027 |
| NCT06457464 | Not yet recruiting | Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients | July 1, 2024 | October 1, 2025 | |
| NCT05611359 | Not yet recruiting | N/A | Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer | January 2023 | December 2026 |
| NCT04062721 | Not yet recruiting | Phase 1 | Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases | June 2021 | September 2024 |
| NCT06458244 | Not yet recruiting | The Efficacy of Allo-HSCT in ND HR-CBF-AML | June 2024 | February 2028 | |
| NCT06458257 | Not yet recruiting | The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia | June 2024 | December 2028 | |
| NCT06353061 | Not yet recruiting | Phase 2 | Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer | April 15, 2024 | February 1, 2026 |
| NCT05183958 | Not yet recruiting | Phase 2 | A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer | December 31, 2021 | December 1, 2025 |
| NCT04384601 | Not yet recruiting | Phase 3 | Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | September 2021 | September 2027 |
| NCT06353646 | Not yet recruiting | N/A | XH001 Combination With Ipilimumab and Chemotherapy for Patients With Resected Pancreatic Cancer | April 2024 | December 2026 |
| NCT04888806 | Not yet recruiting | Phase 2 | A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis | June 1, 2021 | June 30, 2025 |
| NCT06385262 | Not yet recruiting | Phase 2 | TOP 2301: Neoadjuvant Chemo for NSCLC | July 1, 2024 | June 30, 2028 |
| NCT05429515 | Not yet recruiting | Phase 4 | Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury | July 1, 2022 | December 1, 2032 |
| NCT04319874 | Not yet recruiting | Phase 2 | Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma | September 15, 2020 | September 15, 2025 |
| NCT06232434 | Not yet recruiting | Phase 2/Phase 3 | An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II | June 2024 | December 2024 |
| NCT04736589 | Not yet recruiting | Phase 3 | Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway | February 2, 2021 | February 2, 2027 |
| NCT06304545 | Not yet recruiting | Phase 2 | Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab | March 15, 2024 | March 15, 2027 |
| NCT03983811 | Not yet recruiting | N/A | Adjuvant Chemotherapy With or Without Intercalated Icotinib | July 1, 2019 | October 31, 2025 |
| NCT06090864 | Not yet recruiting | Phase 1/Phase 2 | ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells | May 2024 | July 1, 2031 |
| NCT04677673 | Not yet recruiting | Phase 2/Phase 3 | Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients | January 2021 | January 2027 |
| NCT05186506 | Not yet recruiting | Phase 2 | A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer | January 1, 2022 | December 20, 2028 |
| NCT05209256 | Not yet recruiting | Phase 2/Phase 3 | Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC | March 1, 2022 | January 2025 |
| NCT06152978 | Not yet recruiting | Phase 2 | A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma | December 15, 2023 | December 15, 2027 |
| NCT04562727 | Not yet recruiting | N/A | Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study | March 1, 2021 | September 1, 2026 |
| NCT05244798 | Not yet recruiting | Phase 3 | Sintilimab Plus NCT or NCRT Versus NCRT for ESCC | November 1, 2022 | December 31, 2026 |
| NCT05486988 | Not yet recruiting | ctDNA as a Biomarker for Treatment in Advanced NSCLC | July 31, 2022 | June 30, 2025 | |
| NCT04509635 | Not yet recruiting | Phase 3 | Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis | September 1, 2020 | August 31, 2024 |
| NCT06333314 | Not yet recruiting | Phase 2 | Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI | May 2024 | September 2030 |
| NCT05524389 | Not yet recruiting | Phase 3 | Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | December 1, 2022 | June 30, 2027 |
| NCT05684731 | Not yet recruiting | Phase 1 | Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer | February 1, 2023 | June 1, 2026 |
| NCT05862610 | Not yet recruiting | Phase 2 | The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC | July 30, 2023 | June 30, 2027 |
| NCT06383325 | Not yet recruiting | Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment | May 1, 2024 | August 1, 2025 | |
| NCT04951648 | Not yet recruiting | Phase 3 | A Phase III Study to Assess the Efficacy and Safety of Almonertinib Versus Platinum-based Chemotherapy as First-line Therapy in Patients With Locally Advanced or Metastatic NSCLC Harbouring Uncommon EGFR Mutation | July 15, 2021 | September 6, 2024 |
| NCT06196736 | Not yet recruiting | Phase 3 | A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer | December 31, 2023 | December 31, 2028 |
| NCT05979818 | Not yet recruiting | Phase 1 | Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer | December 31, 2023 | December 31, 2026 |
| NCT05633602 | Recruiting | Phase 3 | Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study | March 14, 2023 | March 15, 2028 |
| NCT01927744 | Recruiting | Phase 2 | Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection | December 16, 2013 | December 31, 2024 |
| NCT02153229 | Recruiting | Phase 2 | Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma | May 2014 | December 2024 |
| NCT02265770 | Recruiting | Phase 2/Phase 3 | An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma | June 2, 2015 | August 2031 |
| NCT02276443 | Recruiting | N/A | Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative | November 9, 2015 | November 30, 2026 |
| NCT02634645 | Recruiting | TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) | January 2015 | January 2027 | |
| NCT02806258 | Recruiting | Phase 1/Phase 2 | Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone | April 26, 2016 | December 2025 |
| NCT02843191 | Recruiting | Phase 3 | Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy | December 2016 | July 31, 2024 |
| NCT03015727 | Recruiting | Phase 3 | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma | December 2016 | December 2024 |
| NCT03117036 | Recruiting | Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III | March 1, 2017 | December 28, 2026 | |
| NCT03161522 | Recruiting | Phase 2 | Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer | February 19, 2018 | December 31, 2026 |
| NCT03253107 | Recruiting | Predicting Biomarker of Gastric Cancer Chemotherapy Response | November 30, 2015 | December 31, 2024 | |
| NCT03393741 | Recruiting | Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy | January 29, 2018 | August 2024 | |
| NCT03399253 | Recruiting | Phase 2/Phase 3 | Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor | December 10, 2017 | December 1, 2025 |
| NCT03494946 | Recruiting | N/A | Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer | December 5, 2016 | January 2027 |
| NCT03539406 | Recruiting | Phase 1 | Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients | June 4, 2019 | October 2023 |
| NCT03594630 | Recruiting | Early Phase 1 | Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer | March 13, 2024 | October 31, 2026 |
| NCT03739411 | Recruiting | Phase 1 | Hyperpolarized Imaging in Diagnosing Participants With Glioma | December 9, 2015 | June 30, 2024 |
| NCT03774732 | Recruiting | Phase 3 | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer | March 21, 2019 | September 21, 2026 |
| NCT03785574 | Recruiting | N/A | Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule | December 24, 2018 | September 1, 2025 |
| NCT03803436 | Recruiting | Phase 2 | Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation | January 2, 2019 | January 2024 |
| NCT03804372 | Recruiting | Phase 2 | The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir Alafenamide | July 7, 2020 | July 2024 |
| NCT03875781 | Recruiting | Phase 3 | Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer | June 5, 2019 | December 5, 2026 |
| NCT03896620 | Recruiting | Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma | June 18, 2019 | August 1, 2025 | |
| NCT03930498 | Recruiting | Phase 2 | Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma | March 1, 2020 | December 2025 |
| NCT03957733 | Recruiting | Phase 2/Phase 3 | Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients. | November 23, 2017 | November 23, 2025 |
| NCT03975114 | Recruiting | Phase 2 | A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) | December 20, 2018 | June 30, 2024 |
| NCT03978039 | Recruiting | National Clinical and Biological Sarcoma Database : An Initiative of the French Sarcoma Group | January 2010 | December 2030 | |
| NCT03985891 | Recruiting | Phase 1/Phase 2 | The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer | December 16, 2020 | June 1, 2026 |
| NCT04151940 | Recruiting | N/A | PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer | September 26, 2019 | November 30, 2026 |
| NCT04174079 | Recruiting | N/A | Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma | December 11, 2019 | May 2029 |
| NCT04214717 | Recruiting | N/A | Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor | December 31, 2019 | December 31, 2024 |
| NCT04214730 | Recruiting | N/A | Study of NK Combined With Chemotherapy for Advanced Solid Tumor | December 31, 2019 | December 2023 |
| NCT04288999 | Recruiting | Phase 3 | Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer | October 1, 2019 | October 2028 |
| NCT04302025 | Recruiting | Phase 2 | A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer | November 6, 2020 | March 6, 2029 |
| NCT04322890 | Recruiting | Phase 2 | Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation | April 16, 2020 | December 24, 2027 |
| NCT04359199 | Recruiting | QUantitative Assessment of Swallowing After Radiation (QUASAR) | September 1, 2020 | December 31, 2024 | |
| NCT04570423 | Recruiting | Phase 2 | A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy | May 20, 2021 | October 2027 |
| NCT04575935 | Recruiting | Phase 3 | Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial | August 5, 2020 | December 31, 2028 |
| NCT04588168 | Recruiting | N/A | Multi-parameter Magnetic Resonance Imaging Guides Precise Treatment of Urothelial Carcinoma | January 1, 2018 | June 2026 |
| NCT04638751 | Recruiting | ARGONAUT: Stool and Blood Sample Bank for Cancer Patients | July 1, 2022 | December 31, 2025 | |
| NCT04643366 | Recruiting | Phase 2 | Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer | January 28, 2021 | January 31, 2033 |
| NCT04653480 | Recruiting | Phase 2 | Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC | February 1, 2021 | June 2025 |
| NCT04699539 | Recruiting | N/A | Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer | March 31, 2021 | December 1, 2024 |
| NCT04728724 | Recruiting | Phase 2 | Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer | September 10, 2022 | December 31, 2027 |
| NCT04747054 | Recruiting | Phase 3 | Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers | December 1, 2021 | October 1, 2029 |
| NCT04756713 | Recruiting | Phase 3 | Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia | February 11, 2021 | December 31, 2025 |
| NCT04813705 | Recruiting | Phase 2 | 18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma | January 1, 2022 | June 30, 2029 |
| NCT04870879 | Recruiting | N/A | Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors | October 1, 2020 | October 2025 |
| NCT04943497 | Recruiting | A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia | July 27, 2021 | June 30, 2025 | |
| NCT04952480 | Recruiting | Phase 2 | Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer | June 13, 2022 | November 1, 2025 |
| NCT04975516 | Recruiting | Phase 2 | Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer | July 18, 2023 | July 2, 2027 |
| NCT04997837 | Recruiting | Phase 3 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | July 21, 2021 | October 21, 2027 |
| NCT05011227 | Recruiting | Phase 2 | Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma | August 10, 2021 | August 10, 2025 |
| NCT05036005 | Recruiting | Phase 4 | Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) | July 11, 2021 | July 2023 |
| NCT05111626 | Recruiting | Phase 3 | Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer | March 14, 2022 | September 26, 2026 |
| NCT05145660 | Recruiting | Phase 3 | Optimization of Cervical Nodal CTV for Early and Medium Stage NPC | September 1, 2022 | August 31, 2027 |
| NCT05170594 | Recruiting | Phase 2 | A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer | December 24, 2021 | June 30, 2024 |
| NCT05183984 | Recruiting | Phase 2 | Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer | February 1, 2022 | February 2030 |
| NCT05214482 | Recruiting | Phase 1/Phase 2 | A Study of AK112 in Advanced Malignant Tumors | January 25, 2022 | January 25, 2025 |
| NCT05255302 | Recruiting | Phase 2/Phase 3 | De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction | May 2, 2022 | June 1, 2029 |
| NCT05255653 | Recruiting | Phase 2/Phase 3 | Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features | November 11, 2021 | January 1, 2031 |
| NCT05340491 | Recruiting | Phase 3 | Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial | April 1, 2022 | December 2027 |
| NCT05351320 | Recruiting | Phase 2 | WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC | April 30, 2022 | May 30, 2026 |
| NCT05378334 | Recruiting | N/A | Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients | June 15, 2022 | March 1, 2025 |
| NCT05472467 | Recruiting | Phase 2 | Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer | December 21, 2021 | December 20, 2023 |
| NCT05550090 | Recruiting | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC | September 16, 2022 | December 30, 2025 | |
| NCT05599698 | Recruiting | N/A | Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer | November 15, 2022 | December 30, 2025 |
| NCT05607329 | Recruiting | N/A | Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial | May 1, 2021 | May 1, 2028 |
| NCT05647590 | Recruiting | N/A | SBRT/RT in Oligometastatic Stage IV NSCLC | October 1, 2019 | December 31, 2025 |
| NCT05651802 | Recruiting | N/A | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | January 1, 2023 | June 2026 |
| NCT05667948 | Recruiting | Molecular Analysis and Treatment Options of Thymic Malignancies | January 1, 2016 | December 31, 2026 | |
| NCT05673148 | Recruiting | Phase 3 | Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study | January 10, 2023 | August 12, 2032 |
| NCT05691829 | Recruiting | Phase 2 | Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC | January 24, 2023 | January 2026 |
| NCT05704621 | Recruiting | Phase 2 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance | December 1, 2023 | December 28, 2028 |
| NCT05704985 | Recruiting | Phase 1 | Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | April 3, 2023 | February 2025 |
| NCT05710328 | Recruiting | Phase 2 | Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial | May 10, 2023 | March 31, 2025 |
| NCT05717166 | Recruiting | Phase 3 | A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor. | October 6, 2023 | April 2029 |
| NCT05723107 | Recruiting | Phase 1 | EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) | March 31, 2023 | March 2026 |
| NCT05731947 | Recruiting | Phase 1/Phase 2 | Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors | April 4, 2023 | August 2027 |
| NCT05755672 | Recruiting | On-treatment Biomarkers in Metastatic Colorectal Cancer for Life | March 1, 2023 | March 2033 | |
| NCT05763199 | Recruiting | Phase 2 | Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy | December 1, 2023 | July 1, 2027 |
| NCT05780372 | Recruiting | Phase 3 | Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma | August 8, 2023 | August 2029 |
| NCT05826964 | Recruiting | Phase 2 | Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer | June 12, 2023 | July 31, 2029 |
| NCT05909332 | Recruiting | Phase 3 | Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) | June 20, 2023 | May 30, 2031 |
| NCT05916755 | Recruiting | Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform | January 13, 2023 | December 2029 | |
| NCT05926427 | Recruiting | Phase 2 | Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement | August 10, 2023 | April 30, 2026 |
| NCT05926492 | Recruiting | Phase 2 | A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma | January 9, 2024 | July 2026 |
| NCT05935579 | Recruiting | Phase 2 | Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer | December 14, 2022 | December 30, 2024 |
| NCT05939661 | Recruiting | Phase 2 | A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer | May 25, 2023 | March 31, 2030 |
| NCT05941741 | Recruiting | Phase 3 | IC Plus Low-dose Radiation Plus Cadonilimab in LANPC | January 10, 2024 | December 2029 |
| NCT05945745 | Recruiting | Molecular Analysis and Treatment Options of SCLC | January 1, 2016 | December 31, 2028 | |
| NCT05975749 | Recruiting | Phase 2 | Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer | January 1, 2023 | January 1, 2029 |
| NCT05978193 | Recruiting | Phase 2 | Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma | January 1, 2023 | January 1, 2027 |
| NCT06102837 | Recruiting | Tumor Vaccines for Solid Tumors | October 2023 | October 2027 | |
| NCT06120127 | Recruiting | Phase 2 | Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence | September 25, 2023 | September 25, 2025 |
| NCT06121505 | Recruiting | Phase 2 | Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Advanced Squamous Cell Lung Cancer | January 18, 2024 | February 28, 2027 |
| NCT06121700 | Recruiting | Phase 2 | Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer | January 1, 2023 | December 31, 2027 |
| NCT06195189 | Recruiting | Phase 1/Phase 2 | Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/II | February 29, 2024 | February 1, 2026 |
| NCT06195709 | Recruiting | Phase 3 | ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients | April 17, 2024 | August 15, 2029 |
| NCT06218602 | Recruiting | Phase 2 | Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy. | February 19, 2024 | September 10, 2026 |
| NCT06223711 | Recruiting | Phase 2 | Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC | October 6, 2023 | December 2027 |
| NCT06231680 | Recruiting | Phase 2 | Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP) | January 19, 2024 | September 30, 2025 |
| NCT06370663 | Recruiting | Phase 2 | First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC | April 1, 2024 | April 1, 2026 |
| NCT06376604 | Recruiting | N/A | Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies | September 8, 2021 | December 30, 2025 |
| NCT06402708 | Recruiting | Phase 3 | Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) | April 9, 2024 | May 1, 2030 |
| NCT06408116 | Recruiting | Phase 2 | Predicting Esophageal Cancer Borders Using PET-Imaging | March 1, 2024 | April 2026 |
| NCT06418113 | Recruiting | Phase 1 | Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma | March 21, 2024 | March 21, 2027 |
| NCT06431685 | Recruiting | Phase 1 | Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer | April 25, 2024 | December 2026 |
| NCT05101616 | Suspended | Phase 1/Phase 2 | A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer | July 1, 2022 | January 1, 2027 |
| NCT04558684 | Suspended | Phase 1/Phase 2 | Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer | November 1, 2019 | December 30, 2023 |
| NCT03632798 | Suspended | Phase 3 | Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer | August 1, 2018 | November 30, 2024 |
| NCT02122185 | Suspended | Phase 2 | Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | February 25, 2015 | February 25, 2025 |
| NCT00324831 | Suspended | Phase 3 | GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma | ||
| NCT00042302 | Terminated | Phase 3 | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) | June 2002 | July 2003 |
| NCT01709162 | Terminated | Phase 2 | Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma | March 2013 | July 2014 |
| NCT00740181 | Terminated | Phase 2 | Decitabine, Cytarabine, GCSF for Refractory AML/MDS | August 2008 | April 2010 |
| NCT01094496 | Terminated | Phase 2 | A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) | April 2010 | July 2011 |
| NCT00601848 | Terminated | Phase 2 | Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura | November 2004 | December 2012 |
| NCT01783054 | Terminated | Early Phase 1 | Pilot, Neoadjuvant Gemcitabine and Abraxane Chemotherapy Followed by Surgery, Adenocarcinoma of the Pancreas | July 2012 | |
| NCT01345539 | Terminated | Phase 2 | Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation | June 7, 2013 | October 20, 2022 |
| NCT02621333 | Terminated | Phase 2 | Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma | October 2015 | September 2018 |
| NCT00066807 | Terminated | Phase 3 | Premenopausal Endocrine Responsive Chemotherapy Trial | August 2003 | December 2006 |
| NCT02819752 | Terminated | Phase 1 | PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck | July 12, 2017 | November 28, 2019 |
| NCT00124644 | Terminated | Phase 1 | Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | March 2006 | January 2008 |
| NCT03386162 | Terminated | Phase 2 | SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer | March 15, 2018 | November 18, 2022 |
| NCT01525927 | Terminated | Phase 2 | Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity | August 2010 | December 2011 |
| NCT00004026 | Terminated | Phase 2 | CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy | December 1998 | January 2005 |
| NCT02949843 | Terminated | Phase 2 | Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations | March 10, 2017 | January 12, 2021 |
| NCT00005944 | Terminated | Phase 2 | Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer | July 1, 1999 | October 1, 2003 |
| NCT00042315 | Terminated | Phase 3 | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) | June 2002 | June 2003 |
| NCT00066417 | Terminated | Phase 2 | Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia | January 2007 | |
| NCT00238277 | Terminated | Phase 2 | Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme | February 15, 2005 | December 11, 2007 |
| NCT00003715 | Terminated | Phase 2 | Vaccine Therapy Compared With Interferon Alfa in Treating Patients With Stage III Melanoma | December 1998 | |
| NCT00002863 | Terminated | Phase 1 | Cryosurgery in Treating Patients With Soft Tissue Sarcoma | June 1996 | July 2000 |
| NCT00851110 | Terminated | Phase 2 | Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors | October 2004 | |
| NCT01928615 | Terminated | Phase 2 | A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer | September 2013 | October 2013 |
| NCT01368263 | Terminated | Phase 2 | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | September 2011 | May 2013 |
| NCT01923987 | Unknown status | Phase 2 | Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis | August 2012 | December 2022 |
| NCT01402180 | Unknown status | Phase 2/Phase 3 | Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy | December 2010 | December 2015 |
| NCT04333927 | Unknown status | Phase 2 | Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer | June 1, 2020 | June 2024 |
| NCT04341480 | Unknown status | The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19 | July 1, 2020 | January 10, 2023 | |
| NCT00262067 | Unknown status | Phase 3 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | December 2005 | December 2013 |
| NCT04433169 | Unknown status | Phase 2 | All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck | June 3, 2020 | June 2023 |
| NCT04495387 | Unknown status | Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy | July 2021 | December 2022 | |
| NCT01048463 | Unknown status | Phase 3 | Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor | December 2009 | January 2012 |
| NCT04559308 | Unknown status | Phase 2 | The Effect of Metformin on Breast Cancer Patients | June 1, 2019 | October 2020 |
| NCT04562337 | Unknown status | Phase 2 | A Phase II Clinical Study of SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in Extensive Small Cell Lung Cancer | September 2020 | December 2023 |
| NCT01002092 | Unknown status | Phase 2 | A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma | February 2009 | December 2014 |
| NCT00894153 | Unknown status | Phase 4 | p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage | May 2009 | June 2013 |
| NCT04602013 | Unknown status | Phase 2 | Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma | October 11, 2020 | May 2022 |
| NCT04603586 | Unknown status | N/A | Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses | October 20, 2020 | October 1, 2023 |
| NCT04620954 | Unknown status | Phase 1/Phase 2 | Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin | October 7, 2020 | July 2022 |
| NCT00253409 | Unknown status | N/A | Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery | May 2005 | |
| NCT00002896 | Unknown status | Phase 3 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | September 1993 | |
| NCT00002884 | Unknown status | Phase 3 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | March 1996 | |
| NCT00830544 | Unknown status | Phase 2 | Study of Neoadjuvant Chemotherapy of Breast Cancer | July 2008 | December 2012 |
| NCT00725231 | Unknown status | Phase 3 | Immunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOP | February 2008 | March 2014 |
| NCT00039039 | Unknown status | Phase 3 | Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer | February 2000 | |
| NCT00173472 | Unknown status | Association of MSI, TS, DPD, MVD and EGFR With Chemosensitivity in Stage IV in Colorectal Cancer | July 2002 | July 2005 | |
| NCT04990063 | Unknown status | Phase 1 | Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) | August 8, 2021 | November 30, 2023 |
| NCT03177902 | Unknown status | Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer | June 4, 2017 | June 2019 | |
| NCT03062072 | Unknown status | Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients | April 2015 | December 2022 | |
| NCT03022734 | Unknown status | Phase 2 | Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis | September 2016 | June 2021 |
| NCT03242551 | Unknown status | Phase 2 | Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer | November 8, 2017 | December 31, 2022 |
| NCT03005314 | Unknown status | N/A | Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer | August 2016 | December 2019 |
| NCT02254941 | Unknown status | Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer | August 2014 | December 2022 | |
| NCT02215837 | Unknown status | Phase 2 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | August 2014 | May 2018 |
| NCT03664115 | Unknown status | Phase 2 | Itraconazole in Non Small Cell Lung Cancer | July 2, 2018 | December 2, 2020 |
| NCT03680261 | Unknown status | Phase 3 | Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy | October 1, 2018 | September 30, 2023 |
| NCT02202928 | Unknown status | Phase 2 | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | July 2014 | December 2017 |
| NCT02137928 | Unknown status | Phase 3 | Carboplatin Periocular Injection for Retinoblastoma | January 2006 | December 2015 |
| NCT00452803 | Unknown status | Phase 2 | Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC) | April 2006 | December 2012 |
| NCT00420394 | Unknown status | Phase 2 | Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer | April 2007 | |
| NCT03799692 | Unknown status | Phase 4 | Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer | November 19, 2018 | July 30, 2019 |
| NCT01993979 | Unknown status | Phase 3 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) | May 2012 | May 2022 |
| NCT04319471 | Unknown status | Phase 2 | Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | June 1, 2020 | June 1, 2023 |
| NCT03907098 | Unknown status | Phase 2 | Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer | June 30, 2016 | June 30, 2020 |
| NCT03917069 | Unknown status | Phase 2 | Nab-PCE vs PC for MM After Failure of Anti-PD-1 | March 23, 2019 | September 30, 2022 |
| NCT05322486 | Unknown status | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | October 29, 2020 | December 2022 | |
| NCT03932058 | Unknown status | Proteomics Research of Osteosarcoma | September 1, 2018 | September 1, 2020 | |
| NCT01917695 | Unknown status | Phase 3 | Study on Early Stage Bulky Cervical Cancers | August 2013 | August 2018 |
| NCT01899066 | Unknown status | Phase 2 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | July 2013 | December 2015 |
| NCT00398437 | Unknown status | N/A | Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer | September 2006 | |
| NCT03966456 | Unknown status | Real World Study of Four PD-1 Agents in China | June 1, 2018 | June 1, 2023 | |
| NCT01843647 | Unknown status | Phase 2 | Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients | April 2013 | February 2018 |
| NCT03986528 | Unknown status | Phase 4 | Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) | August 28, 2019 | May 31, 2022 |
| NCT03987087 | Unknown status | Phase 2 | A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC | September 1, 2018 | December 30, 2021 |
| NCT01707329 | Unknown status | Phase 2 | Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment | September 2012 | December 2016 |
| NCT04124731 | Unknown status | Phase 2 | Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE) | October 2019 | April 2022 |
| NCT04134247 | Unknown status | Phase 4 | Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL | November 1, 2019 | November 1, 2021 |
| NCT04136600 | Unknown status | Phase 2 | EGFR Monoclonal Antibody for Advanced Gastric Cancer | July 1, 2019 | December 31, 2021 |
| NCT01665417 | Unknown status | Phase 4 | Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma | August 2012 | December 2017 |
| NCT01567202 | Unknown status | Phase 2 | Study of DC Vaccination Against Glioblastoma | March 2012 | February 1, 2021 |
| NCT05399394 | Unknown status | Phase 2 | Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer | July 1, 2016 | June 1, 2022 |
| NCT00323583 | Unknown status | Phase 2 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | May 2006 | |
| NCT04229537 | Unknown status | Phase 1 | Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC | March 1, 2020 | December 1, 2022 |
| NCT04275986 | Unknown status | Phase 2 | Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma | January 20, 2020 | March 2024 |
| NCT04291092 | Unknown status | Phase 2 | Camrelizumab Combined With Local Treatment in NSCLC Patients With BM | January 1, 2020 | June 30, 2023 |
| NCT02961101 | Unknown status | Phase 1/Phase 2 | Anti-PD-1 Antibody Alone or in Combination With Decitabine/Chemotherapy in Relapsed or Refractory Malignancies | May 2016 | May 2020 |
| NCT02883543 | Unknown status | Phase 3 | First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation | June 2016 | June 2019 |
| NCT03344068 | Unknown status | Phase 2/Phase 3 | Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma | January 1, 2018 | March 31, 2021 |
| NCT02873520 | Unknown status | Phase 1/Phase 2 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer | August 2016 | August 2018 |
| NCT02873416 | Unknown status | Phase 1/Phase 2 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer | August 2016 | August 2018 |
| NCT02862587 | Unknown status | Phase 1/Phase 2 | Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer | August 2016 | August 2018 |
| NCT02862561 | Unknown status | Phase 1/Phase 2 | Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer | August 2016 | July 2018 |
| NCT02860429 | Unknown status | Phase 4 | Clinical Trial of Cinobufacini Injection Combined With Oxaliplatin Regimen on Gastrointestine Carcinoma | September 2016 | |
| NCT02844114 | Unknown status | Phase 2 | Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy | January 2016 | January 2018 |
| NCT02785523 | Unknown status | Phase 3 | Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers | May 2016 | |
| NCT03453255 | Unknown status | Phase 1/Phase 2 | DCHA as Postremission Therapy for AML With t(8;21) | January 1, 2018 | December 31, 2020 |
| NCT02771756 | Unknown status | N/A | The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy | May 2015 | May 2016 |
| NCT02753036 | Unknown status | Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer | January 1, 2016 | June 30, 2023 | |
| NCT03521245 | Unknown status | Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer | October 1, 2017 | May 1, 2022 | |
| NCT03523234 | Unknown status | N/A | Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage | October 2018 | July 2023 |
| NCT02652234 | Unknown status | Phase 1 | Study of Endostar Subcutaneous Injection in NSCLC | August 2015 | September 2016 |
| NCT02503150 | Unknown status | Phase 3 | Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | July 2015 | December 2020 |
| NCT03561142 | Unknown status | Phase 2 | Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy. | June 15, 2018 | April 16, 2024 |
| NCT03563326 | Unknown status | Phase 1 | Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) | August 30, 2018 | December 31, 2022 |
| NCT03589950 | Unknown status | Phase 2 | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer | August 1, 2018 | August 1, 2021 |
| NCT00006112 | Unknown status | Phase 2 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | January 1996 | |
| NCT02448797 | Unknown status | Phase 3 | Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation | June 8, 2015 | December 2023 |
| NCT02363049 | Unknown status | Phase 3 | Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer | July 2014 | July 2018 |
| NCT03601988 | Unknown status | Phase 3 | Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer | July 28, 2018 | July 28, 2022 |
| NCT03234842 | Withdrawn | Phase 2 | Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer | October 30, 2017 | December 11, 2018 |
| NCT04731740 | Withdrawn | Phase 2 | Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer | December 28, 2020 | December 28, 2023 |
| NCT03199144 | Withdrawn | Phase 2 | Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer | April 20, 2017 | March 19, 2021 |
| NCT00003536 | Withdrawn | Phase 2 | Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer | ||
| NCT00389766 | Withdrawn | Phase 2 | High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma | July 2008 | |
| NCT03628144 | Withdrawn | Phase 2 | Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer | July 2020 | September 2023 |
| NCT05481775 | Withdrawn | Phase 2 | Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer | April 1, 2022 | September 30, 2025 |
| NCT00510627 | Withdrawn | Phase 4 | Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases | August 2007 | December 2010 |
| NCT00310128 | Withdrawn | Phase 2 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | February 2006 | |
| NCT00085345 | Withdrawn | Phase 2 | Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma | ||
| NCT03388931 | Withdrawn | Phase 4 | Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx | February 4, 2019 | May 6, 2019 |
| NCT00253526 | Withdrawn | Phase 2 | Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer | ||
| NCT00072228 | Withdrawn | Phase 1 | Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT03135652 | Withdrawn | Phase 2 | Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation | August 1, 2017 | June 1, 2023 |
| NCT00256841 | Withdrawn | Phase 1/Phase 2 | Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy | September 2005 | October 2007 |
| NCT00095641 | Withdrawn | Phase 2 | S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer | ||
| NCT03417037 | Withdrawn | Phase 3 | An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer | May 24, 2018 | August 20, 2025 |
| NCT00101140 | Withdrawn | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission | ||
| NCT04420130 | Withdrawn | N/A | A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009） | August 1, 2020 | August 1, 2023 |
| NCT01531751 | Withdrawn | Phase 2 | High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease | February 2015 | December 2015 |
| NCT00017160 | Withdrawn | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma | ||
| NCT04795596 | Withdrawn | Phase 2/Phase 3 | Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers | April 1, 2021 | April 9, 2022 |
| NCT00873600 | Withdrawn | Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer | October 2007 | ||
| NCT00005969 | Withdrawn | Phase 2 | Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease | September 1999 | |
| NCT05512182 | Withdrawn | Phase 2 | Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression | September 15, 2022 | October 30, 2023 |
| NCT03532204 | Withdrawn | N/A | Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer | April 15, 2019 | August 15, 2023 |
| NCT00458744 | Withdrawn | Phase 1 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | February 2007 | |
| NCT00030355 | Withdrawn | Phase 1/Phase 2 | Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia | ||
| NCT00403182 | Withdrawn | Phase 3 | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | May 2006 | |
| NCT05245760 | Withdrawn | Phase 2 | ChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer | April 2022 | December 2033 |
| NCT00112879 | Withdrawn | Phase 2 | Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma | ||
| NCT00238160 | Withdrawn | Phase 3 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | ||
| NCT01811810 | Withdrawn | N/A | Proton Therapy for High Risk Prostate Cancer | March 2013 | April 2014 |